CN Patent

CN102884057A — 雄激素受体调节剂及其用途

Assigned to Aragon Pharmaceuticals Inc · Expires 2013-01-16 · 13y expired

What this patent protects

本文描述了作为雄激素受体调节剂的化合物。也描述了包含本文描述的化合物的药物组合物和药物，以及单独和与其它化合物联合使用此类雄激素受体调节剂治疗雄激素受体介导或依赖的疾病或状况的方法。

USPTO Abstract

本文描述了作为雄激素受体调节剂的化合物。也描述了包含本文描述的化合物的药物组合物和药物，以及单独和与其它化合物联合使用此类雄激素受体调节剂治疗雄激素受体介导或依赖的疾病或状况的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102884057A
Jurisdiction
CN
Classification
—
Expires
2013-01-16
Drug substance claim
No
Drug product claim
No
Assignee
Aragon Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.